5.95 USD
▲+0.08+1.36%
盘后 5.90 -0.84%
2026-09-15
市值
$292.42M
市盈率
12.46
EPS
0.46
股息率
0.49%
52 周区间
5.80 – 8.92
成交量
20.50K
Beta
0.56
目标价
—
52W 低 5.8052W 高 8.92
价格走势
公司简介
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone; and PRÉNUMBRA, a liquid injectable formulation of afame...